ONE Bio Corp. (ONBI)
USD 0.0
(0.0%)
USD 0.0
(0.0%)
| Year | Operating Expenses | Operating Expenses Growth |
|---|---|---|
| 2010 | 6.44 Million USD | 155.16% |
| 2009 | 2.52 Million USD | 3581.45% |
| 2008 | 68.59 Thousand USD | -79.88% |
| 2007 | 340.86 Thousand USD | 127.45% |
| 2006 | 149.86 Thousand USD | -21.06% |
| 2005 | 189.85 Thousand USD | 0.0% |
| Year | Operating Expenses | Operating Expenses Growth |
|---|---|---|
| 2011 Q1 | 2.04 Million USD | 3.88% |
| 2011 Q3 | 2.68 Million USD | 25.94% |
| 2011 Q2 | 2.13 Million USD | 4.31% |
| 2010 Q4 | 1.97 Million USD | 4.21% |
| 2010 Q3 | 1.89 Million USD | 38.18% |
| 2010 FY | 6.44 Million USD | 155.16% |
| 2010 Q1 | 1.21 Million USD | -5.28% |
| 2010 Q2 | 1.36 Million USD | 12.62% |
| 2009 FY | 2.52 Million USD | 3581.45% |
| 2009 Q4 | 1.28 Million USD | 114.35% |
| 2009 Q3 | 598.38 Thousand USD | 715.73% |
| 2009 Q1 | 15.4 Thousand USD | 11.36% |
| 2009 Q2 | 73.35 Thousand USD | 376.06% |
| 2008 Q1 | 17.83 Thousand USD | -92.23% |
| 2008 FY | 68.59 Thousand USD | -79.88% |
| 2008 Q4 | 13.83 Thousand USD | -40.42% |
| 2008 Q2 | 18.32 Thousand USD | 2.7% |
| 2008 Q3 | 23.22 Thousand USD | 26.78% |
| 2007 FY | 340.86 Thousand USD | 127.45% |
| 2007 Q4 | 229.62 Thousand USD | 865.45% |
| 2007 Q1 | 57.57 Thousand USD | 17.35% |
| 2007 Q3 | 23.78 Thousand USD | -20.42% |
| 2007 Q2 | 29.88 Thousand USD | -48.09% |
| 2006 Q1 | 29.63 Thousand USD | 0.0% |
| 2006 Q2 | 27.21 Thousand USD | -8.18% |
| 2006 Q3 | 43.95 Thousand USD | 61.52% |
| 2006 Q4 | 49.06 Thousand USD | 11.62% |
| 2006 FY | 149.86 Thousand USD | -21.06% |
| 2005 FY | 189.85 Thousand USD | 0.0% |
| Name | Operating Expenses | Operating Expenses Difference |
|---|---|---|
| Burzynski Research Institute, Inc. | 1.33 Million USD | -382.533% |
| Arch Therapeutics, Inc. | 5.04 Million USD | -27.803% |
| Evofem Biosciences, Inc. | 29.55 Million USD | 78.195% |
| Nascent Biotech, Inc. | 2.22 Million USD | -188.979% |
| Rebus Holdings, Inc. | 664 Thousand USD | -870.466% |
| Santhera Pharmaceuticals Holding AG | 37.25 Million USD | 82.704% |
| Qrons Inc. | 643.67 Thousand USD | -901.106% |
| Adynxx, Inc. | - USD | -Infinity% |
| Neon Bloom, Inc. | 389.56 Thousand USD | -1554.121% |
| Northwest Biotherapeutics, Inc. | 57.44 Million USD | 88.782% |
| ProtoKinetix, Incorporated | 415.47 Thousand USD | -1450.955% |
| Skye Bioscience, Inc. | 13.54 Million USD | 52.435% |
| Eiger BioPharmaceuticals, Inc. | 86.78 Million USD | 92.575% |
| Nanobac Pharmaceuticals, Incorporated | 4.91 Million USD | -31.029% |
| Institute of Biomedical Research Corp. | 261.72 Thousand USD | -2362.076% |
| SQZ Biotechnologies Company | 85.61 Million USD | 92.474% |
| Intellipharmaceutics International Inc. | 2.91 Million USD | -120.966% |
| Propanc Biopharma, Inc. | 1.5 Million USD | -329.05% |
| Mesoblast Limited | 5.9 Million USD | -9.181% |
| Marizyme, Inc. | 19.23 Million USD | 66.508% |
| Genus plc | 147.7 Million USD | 95.637% |
| VioQuest Pharmaceuticals, Inc. | 8.77 Million USD | 26.601% |
| Pharming Group N.V. | 225.49 Million USD | 97.142% |
| Therapeutic Solutions International, Inc. | 2.04 Million USD | -214.535% |
| CNBX Pharmaceuticals Inc. | 1.34 Million USD | -380.334% |
| Nymox Pharmaceutical Corporation | 8.33 Million USD | 22.726% |
| ContraFect Corporation | 56.88 Million USD | 88.673% |
| PsyBio Therapeutics Corp. | 4.4 Million USD | -46.164% |
| Sienna Biopharmaceuticals, Inc. | - USD | -Infinity% |
| RegeneRx Biopharmaceuticals, Inc. | 1.47 Million USD | -335.766% |
| IMV Inc. | 37.7 Million USD | 82.912% |
| AXIM Biotechnologies, Inc. | 2.79 Million USD | -130.934% |
| MultiCell Technologies, Inc. | 567.42 USD | -1135547.668% |
| Accustem Sciences Inc. | 3.74 Million USD | -72.001% |
| RVL Pharmaceuticals plc | 85.94 Million USD | 92.502% |
| Arno Therapeutics, Inc. | - USD | -Infinity% |
| EV Biologics, Inc. | 531.96 Thousand USD | -1111.344% |
| Q BioMed Inc. | 3.43 Million USD | -87.506% |
| Emmaus Life Sciences, Inc. | 24.71 Million USD | 73.927% |
| Mosaic ImmunoEngineering Inc. | 2.62 Million USD | -145.246% |
| Biomind Labs Inc. | 994.18 Thousand USD | -548.16% |
| American Oriental Bioengineering, Inc. | 99.33 Million USD | 93.513% |
| Provectus Biopharmaceuticals, Inc. | 1.75 Million USD | -266.197% |
| TetraLogic Pharmaceuticals Corporation | - USD | -Infinity% |
| Oncotelic Therapeutics, Inc. | 6.71 Million USD | 4.08% |
| GlobeStar Therapeutics Corporation | 1.86 Million USD | -245.634% |
| THC Farmaceuticals, Inc. | -25 Thousand USD | 25875.568% |
| Acro Biomedical Co., Ltd. | 16.01 Million USD | 59.751% |
| Curative Biotechnology, Inc. | 1.83 Million USD | -251.148% |
| GB Sciences, Inc. | 1.42 Million USD | -353.633% |
| Alpha Cognition Inc. | 9.7 Million USD | 33.606% |
| HST Global, Inc. | 140.9 Thousand USD | -4473.153% |
| CSL Limited | 3.44 Billion USD | 99.813% |
| Wesana Health Holdings Inc. | 1.12 Million USD | -472.836% |
| Halberd Corporation | 74.84 Thousand USD | -8509.994% |
| Enzolytics Inc. | 2.17 Million USD | -195.658% |
| Agentix Corp. | 1.37 Million USD | -369.755% |
| Resverlogix Corp. | 12.71 Million USD | 49.309% |
| Nuo Therapeutics, Inc. | 3.65 Million USD | -76.511% |
| MetaStat, Inc. | - USD | -Infinity% |
| argenx SE | 1.53 Billion USD | 99.58% |
| Enzon Pharmaceuticals, Inc. | 1.04 Million USD | -517.231% |
| Endonovo Therapeutics, Inc. | 2.4 Million USD | -167.945% |
| RespireRx Pharmaceuticals Inc. | 1.57 Million USD | -308.008% |
| GeneThera, Inc. | - USD | -Infinity% |
| Inhibitor Therapeutics, Inc. | 3.4 Million USD | -89.249% |
| AVAX Technologies, Inc. | 7.31 Million USD | 11.851% |
| Zenith Capital Corp. | 8.94 Million USD | 27.945% |
| Genscript Biotech Corporation | 825.34 Million USD | 99.219% |
| Ember Therapeutics, Inc. | 17.42 Thousand USD | -36889.22% |
| Anthera Pharmaceuticals, Inc. | - USD | -Infinity% |
| Sigyn Therapeutics, Inc. | 2.45 Million USD | -162.446% |
| WPD Pharmaceuticals Inc. | 171.5 Thousand USD | -3657.174% |
| Cotinga Pharmaceuticals Inc. | 1.92 Million USD | -235.461% |
| Kadimastem Ltd | 2.41 Million USD | -167.369% |
| Helix BioMedix, Inc. | 1.97 Million USD | -226.764% |
| VitaSpring Biomedical Co. Ltd. | - USD | -Infinity% |
| Capstone Therapeutics Corp. | 10.86 Million USD | 40.702% |
| BioStem Technologies, Inc. | 22.97 Million USD | 71.952% |
| Oncology Pharma Inc. | - USD | -Infinity% |
| Reve Technologies, Inc. | 181.48 Thousand USD | -3450.647% |
| LadRx Corporation | 3.81 Million USD | -69.052% |
| Cell Source, Inc. | 4.32 Million USD | -48.98% |
| Regen BioPharma, Inc. | 923.51 Thousand USD | -597.761% |
| Regen BioPharma, Inc. | 923.51 Thousand USD | -597.761% |
| NovAccess Global Inc. | 2.46 Million USD | -161.229% |
| Affymax, Inc. | 39.38 Million USD | 83.639% |
| Itoco Inc. | 919.14 Thousand USD | -601.076% |
| Rasna Therapeutics, Inc. | 4.23 Million USD | -52.035% |
| Pathfinder Cell Therapy, Inc. | 1.11 Million USD | -475.862% |
| Mobile Lads Corp. | 554.54 Thousand USD | -1062.012% |
| CytoDyn Inc. | 18.05 Million USD | 64.316% |
| Claritas Pharmaceuticals, Inc. | - USD | -Infinity% |
| NDT Pharmaceuticals Inc. | 25.16 Thousand USD | -25502.495% |
| NanoSphere Health Sciences Inc. | 220.07 Thousand USD | -2828.004% |
| Alseres Pharmaceuticals, Inc. | 1.41 Million USD | -353.862% |
| SYBLEU INC | 160.87 Thousand USD | -3905.502% |
| Advanced Proteome Therapeutics Corporation | - USD | -Infinity% |
| ImmunoCellular Therapeutics, Ltd. | 1.81 Million USD | -254.777% |
| International Stem Cell Corporation | 5.27 Million USD | -22.252% |
| Bioxytran, Inc. | 3.82 Million USD | -68.682% |
| GlobeImmune, Inc. | - USD | -Infinity% |
| Predictive Technology Group, Inc. | - USD | -Infinity% |
| ProText Mobility, Inc. | 52.64 Thousand USD | -12140.971% |
| Cardax, Inc. | - USD | -Infinity% |
| VG Life Sciences Inc. | 20.34 Thousand USD | -31576.213% |
| Kaleido Biosciences, Inc. | - USD | -Infinity% |
| Advaxis, Inc. | 36.26 Million USD | 82.232% |
| Adhera Therapeutics, Inc. | 1.61 Million USD | -298.263% |
| RenovaCare, Inc. | - USD | -Infinity% |
| Regnum Corp. | 735.83 Thousand USD | -775.725% |
| Innovation Pharmaceuticals Inc. | 3.11 Million USD | -107.132% |
| Neutra Corp. | 243.82 Thousand USD | -2542.878% |
| Windtree Therapeutics, Inc. | 17.45 Million USD | 63.087% |
| PureTech Health plc | 144.59 Million USD | 95.544% |
| Coeptis Therapeutics, Inc. | 20.48 Million USD | 68.551% |
| IXICO plc | 4.7 Million USD | -36.9% |
| IntelGenx Technologies Corp. | 8.79 Million USD | 26.749% |
| Gelesis Holdings, Inc. | 117.74 Million USD | 94.527% |
| CSL Limited | 3.89 Billion USD | 99.834% |
| Cellectis S.A. | 97.32 Million USD | 93.379% |